American Health Packaging is recalling 11 lots of Ranitidine tablets.
The medication, used for treatment of ulcers, may be contaminated with N-nitrosodimethylamine (NDMA), a probable cancer-causer.
There are no reports of injury or adverse events to date.
The following lots of the histamine-2 blocker, which decreases the amount of acid created by the stomach, are being recalled:
Product Description | AHP Lot No. | Expiration Date |
|---|
AHP Ranitidine Tablets, USP 150 mg, 100 count Unit Dose Blisters
Carton NDC#: 60687-322-01
(Individual Dose NDC: 60687-322-11) | 179516 | 12/31/2019 |
| 179745 | 12/31/2019 |
| 180712 | 02/29/2020 |
| 180819 | 04/30/2020 |
| 181403 | 05/31/2020 |
| 182544 | 05/31/2020 |
| 183155 | 05/31/2020 |
| 183236 | 05/31/2020 |
| 185739 | 12/31/2020 |
| 186600 | 12/31/2020 |
| 186702 | 12/31/2020 |
The recalled product was distributed to wholesalers nationwide for use in hospitals.
What to do
Pharmacies that have received the recalled product should contact the company at (877) 475-5864 from 9:00 am - 5:00 pm (EST) Monday thru Friday to receive a return packet.
Consumers who have the recalled products should stop using them, and may contact Inmar Pharmaceuticals Services at (800) 967-5952 (option 1) from 9:00 am - 5:00 pm (EST) Monday through Friday for more information.
American Health Packaging is recalling 11 lots of Ranitidine tablets.
The medication, used for treatment of ulcers, may be contaminated with N-nitrosodi...